kras mutation and glutathion Mutations in Cancer: Understanding Signaling Pathways to Immune Regulation the Potential of Immunotherapy Targeting KRAS Mutant Cancers with
Targeting KRAS Mutant Cancers with a Covalent G12C Specific Inhibitor: Cell KRAS G12V mutation selective requirement for ACSS2 in colorectal adenoma formation: Cell Reports KRAS Screening and Profiling Services Kinetic and Redox Characterization of KRAS G12C Inhibition bioRxiv
Pay in 4 interest-free payments of $6.83 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



